MSCRAMM - What does MSCRAMM stand for? Acronyms and abbreviations by the Free Online Dictionary.

Acronym

Definition

MSCRAMM

Microbial Surface Components Recognizing Adhesive Matrix Molecules

? References in periodicals archive
During the second quarter we made considerable progress in our strategy to build a pipeline of high-value antivirals and capitalize on the potential of our MSCRAMM platform, setting the stage for what we anticipate will be a dynamic second half of the year," stated Russell H. Inhibitex Reports Second Quarter 2007 Financial Results by Business Wire Under the terms of the agreement, Inhibitex granted 3M an exclusive global license to use Clumping Factor A (ClfA), an MSCRAMM protein, in the development of diagnostic products in exchange for license fees, future milestone payments, financial support of further research and development activities and royalty payments on product sales that are expected to exceed $4. Inhibitex Reports First Quarter 2007 Financial Results by Business Wire We also intend to continue to seek ways to further leverage or monetize our MSCRAMM platform and related intellectual property, which we have already demonstrated in 2007 with our recent agreement with the 3M Company for the development of diagnostic products. Inhibitex Reports Fourth Quarter and 2006 Fiscal Year Financial ... by Business Wire More results

? References in periodicals archive

During the second quarter we made considerable progress in our strategy to build a pipeline of high-value antivirals and capitalize on the potential of our MSCRAMM platform, setting the stage for what we anticipate will be a dynamic second half of the year," stated Russell H.

Inhibitex Reports Second Quarter 2007 Financial Results by Business Wire

Under the terms of the agreement, Inhibitex granted 3M an exclusive global license to use Clumping Factor A (ClfA), an MSCRAMM protein, in the development of diagnostic products in exchange for license fees, future milestone payments, financial support of further research and development activities and royalty payments on product sales that are expected to exceed $4.

Inhibitex Reports First Quarter 2007 Financial Results by Business Wire

We also intend to continue to seek ways to further leverage or monetize our MSCRAMM platform and related intellectual property, which we have already demonstrated in 2007 with our recent agreement with the 3M Company for the development of diagnostic products.

Inhibitex Reports Fourth Quarter and 2006 Fiscal Year Financial ... by Business Wire

More results